Purpose: To evaluate the safety of a new injector, the Raysert R-INJ-04/18, for implantation of the C-flex intraocular lens (IOL).
Setting: Ophthalmology Department, Kaplan Medical Center, Rehovot, Israel.
Design: Experimental study.
Methods: Sixty IOLs were subdivided into 2 equally sized groups. Group A IOLs were injected using the established R-INJ-04 injector, and those in Group B were injected with the new injector. The IOLs were injected into a Petri dish. Subsequently, all IOLs and injectors were evaluated macroscopically and microscopically and then photographed under light microscopy (LM). Two IOLs in each group were randomly chosen and sent for evaluation by scanning electron microscopy (SEM) and energy dispersive analysis of x-ray. All remaining IOLs were sent for power and modulation transfer function (MTF) analysis.
Results: All Group B IOLs were successfully injected without evident signs of scratching, cracks, or deposits on LM and SEM examination. In Group A, findings were confined to a singular incidence of a small deposit detected on the periphery of the posterior optical surface of the IOL, with corresponding findings detected on the injector nozzle. No signs of scratching, cracks, or deposits were found in the rest of the IOLs or injectors. The power and MTF analyses were within the normal range for all IOLs.
Conclusion: The new 1.8 mm external diameter soft-tipped injector for 2.4 to 2.2 mm incisions was shown to be safe for the implantation of the C-flex 21.0 diopter IOL.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jcrs.2010.12.062 | DOI Listing |
Eur J Ophthalmol
November 2024
Department of Retina, Rothschild Foundation Hospital, Paris, France.
Purpose: To compare the refractive outcomes and the complications of implantation surgery by the Carlevale IOL to the Artisan iris-claw IOL.
Methods: Retrospective comparative study of consecutive surgical cases between 2019 and 2021 in our tertiary centre in Paris, France.
Results: We included 142 eyes in the Artisan group and 63 in the Carlevale group.
Polymers (Basel)
September 2024
School of Materials Science and Engineering, Dalian University of Technology, Dalian 116024, China.
Bioact Mater
November 2024
National Engineering Research Center of Ophthalmology and Optometry, School of Biomedical Engineering, School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, China.
Cataract patients look forwards to fewer postoperative complications and higher vision quality after surgery. However, the current intraocular lens (IOL) implanted after cataract surgery neither can adjust focal length in response to ciliary muscle contraction as natural lens nor have the ability to prevent postoperative complications. Herein, a thermosensitve Poloxamer based hybrid hydrogel with antibacterial anti-inflammatory and photothermal functional elements doping was designed and used as injectable, in situ curable, and adjustable IOL (FHTAB IOL).
View Article and Find Full Text PDFJpn J Ophthalmol
September 2024
Department of Ophthalmology, Miyata Eye Hospital, Miyazaki, Japan.
J Cataract Refract Surg
October 2024
From the Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland (Rocher); Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland (Eghrari).
Purpose: To develop and assess the utility of an ophthalmic viscosurgical device (OVD) manufactured with fluorescein-conjugated hyaluronic acid (conjHA).
Setting: Department of Biomedical Engineering and the Wilmer Eye Institute, Johns Hopkins University and School of Medicine, Baltimore, Maryland.
Design: Laboratory study.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!